<p>Past, Present, and Future of Anticancer Nanomedicine</p>

Abstract

This review aims to summarize the methods that have been used till today, highlight methods that are currently being developed, and predict the future roadmap for anticancer therapy. In the beginning of this review, established approaches for anticancer therapy, such as conventional chemotherapy, hormonal therapy, monoclonal antibodies, and tyrosine kinase inhibitors are summarized. To counteract the side effects of conventional chemotherapy and to increase limited anticancer efficacy, nanodrug- and stem cell-based therapies have been introduced. However, current level of understanding and strategies of nanodrug and stem cell-based therapies have limitations that make them inadequate for clinical application. Subsequently, this manuscript reviews methods with fewer side effects compared to those of the methods mentioned above which are currently being investigated and are already being applied in the clinic. The newer strategies that are already being clinically applied include cancer immunotherapy, especially T cell-mediated therapy and immune checkpoint inhibitors, and strategies that are gaining attention include the manipulation of the tumor microenvironment or the activation of dendritic cells. Tumor-associated macrophage repolarization is another potential strategy for cancer immunotherapy, a method which activates macrophages to immunologically attack malignant cells. At the end of this review, we discuss combination therapies, which are the future of cancer treatment. Nanoparticle-based anticancer immunotherapies seem to be effective, in that they effectively use nanodrugs to elicit a greater immune response. The combination of these therapies with others, such as photothermal or tumor vaccine therapy, can result in a greater anticancer effect. Thus, the future of anticancer therapy aims to increase the effectiveness of therapy using various therapies in a synergistic combination rather than individually.

Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives

“…Nowadays, a central area for the use of nanomedical products, considering the number of scientific publications and product approvals by regulatory agencies, is cancer treatment [162]. The conventional cytotoxic anticancer therapy is often associated with low therapeutic efficacy and increased systemic toxicity.…”

Lipid nanostructures for targeting brain cancer

“…Conventional strategies to combat cancer include the use of anticancer drugs (chemotherapy), surgery, and radiotherapy. Both surgery and radiotherapy are most effective in early stage tumors, but are insufficient for stage III and IV tumors, and the use of chemotherapy becomes essential [10]. In this respect, drug delivery (either passive or targeted) is becoming very promising in reducing the side effects and increasing the therapeutic index of chemotherapy.…”

A Tri-Stimuli Responsive (Maghemite/PLGA)/Chitosan Nanostructure with Promising Applications in Lung Cancer

“…Control of the in-vivo fate of antitumour agents (genes and/or drugs), when they are site-specific delivered by biodegradable and biocompatible nanoparticles (NPs), has been reported to optimize cancer therapy outcomes in terms of efficacy and safety [ 1 , 2 , 3 ]. Remarkably, Nanotechnology has also contributed to the implementation of combination therapies against this malignant disease, e.g., chemotherapy and photodynamic therapy [ 4 ], chemotherapy and photothermal therapy [ 5 ], and chemotherapy and hyperthermia [ 6 ].…”